Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Harper

Showing results (1371-1380 of 1,385) with videos related to

Pageof 139
Sort By:
Ecology and Evolution|January 27, 2016
Oxidative stress and life histories: unresolved issues and current needsJohn R Speakman, Jonathan D Blount, Anne M Bronikowski, et al.
Neurology|June 13, 2024
Incidence and Types of Cardiac Arrhythmias in the Peri-Ictal Period in Patients Having a Generalized Convulsive SeizureLaura Vilella, Christina Y Miyake, Ganne Chaitanya, et al.
Neurology|December 3, 2020
Association of Peri-ictal Brainstem Posturing With Seizure Severity and Breathing Compromise in Patients With Generalized Convulsive SeizuresLaura Vilella, Nuria Lacuey, Johnson P Hampson, et al.
Biological Reviews of the Cambridge Philosophical Society|August 2, 2020
Deciphering mollusc shell production: the roles of genetic mechanisms through to ecology, aquaculture and biomimeticsMelody S Clark, Lloyd S Peck, Jaison Arivalagan, et al.
The Journal of Infectious Diseases|October 5, 2013
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observationAnne Szarewski, S Rachel Skinner, Suzanne M Garland, et al.
The Lancet. Oncology|May 3, 2005
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLuisa L Villa, Ronaldo L R Costa, Carlos A Petta, et al.
Clinical and Vaccine Immunology : CVI|December 26, 2014
Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNAFrank Struyf, Brigitte Colau, Cosette M Wheeler, et al.
Journal of Natural Products|September 3, 2016
Analogues of Marine Guanidine Alkaloids Are in Vitro Effective against Trypanosoma cruzi and Selectively Eliminate Leishmania (L.) infantum Intracellular AmastigotesLigia F Martins, Juliana T Mesquita, Erika G Pinto, et al.
Lancet (London, England)|September 20, 2025
Risk markers for sudden unexpected death in epilepsy: an observational, prospective, multicentre cohort studyManuela Ochoa-Urrea, Xi Luo, Laura Vilella, et al.
Lancet (London, England)|December 8, 2009
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years, B Romanowski, P Colares de Borba, et al.
Pageof 139

Showing results (1371-1380 of 1,385) with videos related to

Sort By:
Pageof 139
Ecology and Evolution|January 27, 2016
Oxidative stress and life histories: unresolved issues and current needsJohn R Speakman, Jonathan D Blount, Anne M Bronikowski, et al.
Neurology|June 13, 2024
Incidence and Types of Cardiac Arrhythmias in the Peri-Ictal Period in Patients Having a Generalized Convulsive SeizureLaura Vilella, Christina Y Miyake, Ganne Chaitanya, et al.
Neurology|December 3, 2020
Association of Peri-ictal Brainstem Posturing With Seizure Severity and Breathing Compromise in Patients With Generalized Convulsive SeizuresLaura Vilella, Nuria Lacuey, Johnson P Hampson, et al.
Biological Reviews of the Cambridge Philosophical Society|August 2, 2020
Deciphering mollusc shell production: the roles of genetic mechanisms through to ecology, aquaculture and biomimeticsMelody S Clark, Lloyd S Peck, Jaison Arivalagan, et al.
The Journal of Infectious Diseases|October 5, 2013
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observationAnne Szarewski, S Rachel Skinner, Suzanne M Garland, et al.
The Lancet. Oncology|May 3, 2005
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLuisa L Villa, Ronaldo L R Costa, Carlos A Petta, et al.
Clinical and Vaccine Immunology : CVI|December 26, 2014
Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNAFrank Struyf, Brigitte Colau, Cosette M Wheeler, et al.
Journal of Natural Products|September 3, 2016
Analogues of Marine Guanidine Alkaloids Are in Vitro Effective against Trypanosoma cruzi and Selectively Eliminate Leishmania (L.) infantum Intracellular AmastigotesLigia F Martins, Juliana T Mesquita, Erika G Pinto, et al.
Lancet (London, England)|September 20, 2025
Risk markers for sudden unexpected death in epilepsy: an observational, prospective, multicentre cohort studyManuela Ochoa-Urrea, Xi Luo, Laura Vilella, et al.
Lancet (London, England)|December 8, 2009
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years, B Romanowski, P Colares de Borba, et al.
Pageof 139